ITCMDBv1
Clinical TrialID 122

Angelica Gigas Dietary Supplements and Human Immune Cells

NCT03630328

Innate Immune Cells

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
122
Evidence Id
122
Core Evidence Id
122
Source Clinical Trial Id
117
Herb2 Clinical Trial Id
HBCT000117
Nct Id
NCT03630328
Title
Angelica Gigas Dietary Supplements and Human Immune Cells
Status
Active_Not_Recruiting
Phase
Study Result
No
Study Condition
Innate Immune Cells
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
Intervention
DIETARY_SUPPLEMENT: Cogni.Q|OTHER: Placebo
Intervention Allocation
Randomized
Intervention Model
Crossover
Intervention Mask
Triple
Intervention Purpose
Basic_Science
Gender
Male
Age
Adult, Older_Adult
Enrollment
40
Outcome Measure
Neutrophil counts and NK cell counts in peripheral blood, Using CBC diff to measure neutrophil counts, NK cells number will be enumerated using flowcytometer, 70 days
Sponsor Collaborator
Milton S. Hershey Medical Center
Funded By
OTHER
Location
Penn State College of Medicine, Hershey, Pennsylvania, 17033, United States
Other Id
STUDY00008009
Start Date
2019-02-06
Primary Completion Date
2025-08
Completion Date
2025-12
First Posted
2018-08-14
Results First Posted
Last Update Posted
2024-02-26
Study Document
Study Protocol and Statistical Analysis Plan, https://cdn.clinicaltrials.gov/large-docs/28/NCT03630328/Prot_SAP_000.pdf
Study Url
https://clinicaltrials.gov/study/NCT03630328
Title Cn
Title En
Angelica Gigas Dietary Supplements and Human Immune Cells
Bilingual Status
semi_complete